🇮🇳IN
Sign In
BI

BIOFILCHEM

NSE

Biofil Chemicals & Pharmaceuticals Limited

₹29.34

-0.92(-3.04%)

Value & Investment Index

VII

VII Detail

90 days · zone the stock traded in

Multiples vs Peers

Quality Scores

Versus Its Own History

P/E · P/B percentile bands

Scenario analysis

stated assumptions, shown workings

BIOFILCHEM valuation summary

Biofil Chemicals & Pharmaceuticals Limited trades at 91.9 times trailing earnings. Return on equity is -2.8% and return on capital employed is 3.0%. That P/E equals an earnings yield of 1.1%. The median P/E across 101 listed Drug Manufacturers - Specialty & Generic companies is 33.3, so Biofil Chemicals & Pharmaceuticals Limited trades at a 419% premium to that median.

P/E91.9
ROE-2.8%
ROCE3.0%

Investment in securities market are subject to market risks. Read all the related documents carefully before investing. Disclaimer